[1] Report any concerning symptoms promptly, including severe abdominal pain (which may indicate pancreatitis), right upper quadrant pain (possible gallbladder issues), persistent nausea or vomiting leading to dehydration, changes in vision, symptoms of thyroid nodules (neck mass, difficulty swallowing), or signs of kidney problems (decreased urination, swelling)
You should not skip your dose without consulting your healthcare provider
The results, released in February 2021, were important enough to warrant prominent placement in the New England Journal of Medicine for the STEP 1 trial results and Journal of the American Medical Association for STEP 3 trial results
Compounded semaglutide at a legitimate 503B facility has real costs
Obesity (Silver Spring) (2011) 19(2):38895.10.1038/oby.2010.198 42 TurcotVTchernofADeshaiesYPerusseLBelisleAMarceauPet alComparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome